Koyfin Home > Directory > Health Care > Akebia Therapeutics > Net Debt / EBITDA

Akebia Therapeutics Net Debt / EBITDA Chart (AKBA)

Akebia Therapeutics annual/quarterly Net Debt / EBITDA from 2012 to 2020. Net Debt / EBITDA is a measure of leverage for a company by dividing the Debt less Cash on hand vs. EBITDA.
  • Akebia Therapeutics Net Debt / EBITDA for the quarter ending June 06, 2020 was $3m a 55.34% increase of 1m year over year
  • Akebia Therapeutics Net Debt / EBITDA for the last 12 months ending June 06, 2020 was $1m a 47.11% increase of 1m year over year
  • Akebia Therapeutics Annual Net Debt / EBITDA for 2019 was $0m a -761.09% decrease of -2m from 2018
  • Akebia Therapeutics Annual Net Debt / EBITDA for 2018 was $2m a -101.49% decrease of -2m from 2017
  • Akebia Therapeutics Annual Net Debt / EBITDA for 2017 was $4m a 54.24% increase of 2m from 2016
Other Ratios Metrics:
  • Akebia Therapeutics Total Debt / Capital for the quarter ending December 12, 2018 was $2m a 99.29% increase of 2m year over year
  • Akebia Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $95m a 0.76% increase of 1m year over year
  • Akebia Therapeutics Total Debt / Equity for the quarter ending December 12, 2018 was $2m a 99.31% increase of 2m year over year
View Chart On Koyfin

Quarterly AKBA Net Debt / EBITDA Data

06/2020$3m
03/2020$0m
12/2019$0m
09/2019$1m
06/2019$1m
03/2019$1m
12/2018$1m
09/2018$4m
06/2018$3m
03/2018$4m

Annual AKBA Net Debt / EBITDA Data

2019$0m
2018$2m
2017$4m
2016$2m
2015$2m
2014$3m
2013$2m
2012$0m
2011$0m